GSZ
3 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Antigens, Febrile (Weil-Felix), All Groups
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 866.3410
- Medical specialty
- Microbiology
- Adverse events (MAUDE)
- 1996: 1
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| PROTEUS OX-19 IFA* (K885110) | Investigacion Farmaceutica S.A. DE C.V. | 1989-08-15 |
| FEBRILE ANTIGEN CONTROL SERA (K760881) | Bd Becton Dickinson Vacutainer Systems Preanalytic | 1976-11-09 |
| FEBRILE ANTIGENS & CONTROL SERUMS (K760097) | Gamma Biologicals, Inc. | 1976-08-03 |
Track GSZ automatically
Every clearance here is in the API, with alerts when new ones post.